![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Kwong Ming Fock
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.47, Iss.1, 2008-01, pp. : 1-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imidapril: Will Fewer Adverse Events Translate into Better Long-Term Outcomes?
By Richart Tom
Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prescribing Proton Pump Inhibitors: Is it Time To Pause and Rethink?
By Vakil Nimish
Drugs, Vol. 72, Iss. 4, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
How Important Are Gender Differences in Pharmacokinetics?
By Meibohm B.
Clinical Pharmacokinetics, Vol. 41, Iss. 5, 2002-01 ,pp. :